|Mr. Andrew Douglas Bowden||CEO & Director||169.23k||N/A||1988|
|Mr. Robert E. Mikkelsen||Sec., Treasurer & CFO||134.62k||N/A||1982|
|Mr. Christopher Leland Wolven||Chief Operating Officer||155.77k||N/A||1983|
|Mr. Jeffrey I. Rassas||Chief Strategy Officer & Director||196.7k||N/A||1963|
|Mr. Mike Keskey II||Gen. Counsel||N/A||N/A||N/A|
|Jayne Levy||Director of Communications||N/A||N/A||N/A|
|Kyle Jennings||VP of Marketing||N/A||N/A||N/A|
|Mr. Michael Weinberger||Chief Franchise Officer & Director||N/A||N/A||1978|
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers products through licensed dispensaries to consumers in Arizona. As of July 7, 2021, the company had one dispensary. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Item 9 Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.